title: Successful treatment of severe delayed pressure angio-oedema with omalizumab.
authors: Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Principe de Asturias, Departamento de Medicina, Universidad de Alcalá, Hospital Universitario Príncipe de Asturias, Madrid, Spain. Electronic address: mercedesrr@gmail.com.
authors: M
authors: M
authors: Rodríguez-Rodríguez
authors: Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Principe de Asturias, Departamento de Medicina, Universidad de Alcalá, Hospital Universitario Príncipe de Asturias, Madrid, Spain. Electronic address: dario.antolin@gmail.com.
authors: D
authors: D
authors: Antolin-Amerigo
authors: Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Principe de Asturias, Departamento de Medicina, Universidad de Alcalá, Hospital Universitario Príncipe de Asturias, Madrid, Spain. Electronic address: jose.barbarroja@uah.es.
authors: J
authors: J
authors: Barbarroja-Escudero
authors: Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Principe de Asturias, Departamento de Medicina, Universidad de Alcalá, Hospital Universitario Príncipe de Asturias, Madrid, Spain. Electronic address: medicimj@yahoo.es.
authors: M J
authors: MJ
authors: Sánchez-González
authors: Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Principe de Asturias, Departamento de Medicina, Universidad de Alcalá, Hospital Universitario Príncipe de Asturias, Madrid, Spain. Electronic address: mademons@gmail.com.
authors: M
authors: M
authors: Alvarez-Mon
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000799:Angioedema / Q000276:immunology / Q000628:therapy*; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008875:Middle Aged; D000069444:Omalizumab; D011312:Pressure / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab